Michl P - Search Results

1

The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer.

Müller S, Bley N, Busch B, Glaß M, Lederer M, Misiak C, Fuchs T, Wedler A, Haase J, Bertoldo JB, Michl P, Hüttelmaier S. Müller S, et al. Among authors: michl p. Nucleic Acids Res. 2020 Sep 4;48(15):8576-8590. doi: 10.1093/nar/gkaa653. Nucleic Acids Res. 2020. PMID: 32761127 Free PMC article.

2

Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.

Krug S, Abbassi R, Griesmann H, Sipos B, Wiese D, Rexin P, Blank A, Perren A, Haybaeck J, Hüttelmaier S, Rinke A, Gress TM, Michl P. Krug S, et al. Among authors: michl p. Int J Cancer. 2018 Oct 1;143(7):1806-1816. doi: 10.1002/ijc.31562. Int J Cancer. 2018. PMID: 29696624 Free article.

3

RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma.

Glaß M, Michl P, Hüttelmaier AS. Glaß M, et al. Among authors: michl p. Int J Mol Sci. 2020 Jun 11;21(11):4190. doi: 10.3390/ijms21114190. Int J Mol Sci. 2020. PMID: 32545414 Free PMC article.

4

Targeting HDACs in Pancreatic Neuroendocrine Tumor Models.

Schmitz RL, Weissbach J, Kleilein J, Bell J, Hüttelmaier S, Viol F, Clauditz T, Grabowski P, Laumen H, Rosendahl J, Michl P, Schrader J, Krug S. Schmitz RL, et al. Among authors: michl p. Cells. 2021 Jun 6;10(6):1408. doi: 10.3390/cells10061408. Cells. 2021. PMID: 34204116 Free PMC article.

5

IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2.

Sperling F, Misiak D, Hüttelmaier S, Michl P, Griesmann H. Sperling F, et al. Among authors: michl p. Cancers (Basel). 2022 Apr 24;14(9):2121. doi: 10.3390/cancers14092121. Cancers (Basel). 2022. PMID: 35565249 Free PMC article.

6

Targeted therapy of pancreatic cancer: biomarkers are needed.

Kleeff J, Michl P. Kleeff J, et al. Among authors: michl p. Lancet Oncol. 2017 Apr;18(4):421-422. doi: 10.1016/S1470-2045(17)30087-6. Epub 2017 Mar 2. Lancet Oncol. 2017. PMID: 28259609 No abstract available.

7

Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines.

Weber CK, Sommer G, Michl P, Fensterer H, Weimer M, Gansauge F, Leder G, Adler G, Gress TM. Weber CK, et al. Among authors: michl p. Gastroenterology. 2001 Sep;121(3):657-67. doi: 10.1053/gast.2001.27222. Gastroenterology. 2001. PMID: 11522750

8

Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

Michl P, Buchholz M, Rolke M, Kunsch S, Löhr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM. Michl P, et al. Gastroenterology. 2001 Sep;121(3):678-84. doi: 10.1053/gast.2001.27124. Gastroenterology. 2001. PMID: 11522752

9

Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, Gress TM, Ellenrieder V. Buchholz M, et al. Among authors: michl p. EMBO J. 2006 Aug 9;25(15):3714-24. doi: 10.1038/sj.emboj.7601246. Epub 2006 Jul 27. EMBO J. 2006. PMID: 16874304 Free PMC article.

10

WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.

Ripka S, König A, Buchholz M, Wagner M, Sipos B, Klöppel G, Downward J, Gress T, Michl P. Ripka S, et al. Among authors: michl p. Carcinogenesis. 2007 Jun;28(6):1178-87. doi: 10.1093/carcin/bgl255. Epub 2007 Jan 16. Carcinogenesis. 2007. PMID: 17227781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters